Table 1.
Training Set | Validation Set | |||
HC + SSc without PH | IPAH + SSc-PAH | HC + SSc without PH | IPAH + SSc-PAH | |
No. Sheffield samples | 14 + 7 | 23 + 11 | 7 + 3 | 11 + 7 |
No. Imperial Samples | 8 + 0 | 8 + 0 | 4 + 0 | 4 + 0 |
Total sample no. | 29 | 42 | 14 | 22 |
Mean age at sampling (years) | 54.1 (14.5) | 56.5 (14.3) | 51.6 (11.7) | 57.4 (15.3) |
Female (%) | 12 + 6 (58.1%) | 18 + 6 (57.1%) | 7 + 3 (71.4%) | 8 + 6 (63.6%) |
Alive 5 years follow up (%) | 28 (97%) | 28 (65%) | 14 (100%) | 9 (43%) |
WHO Functional class (1,2,3,4) | - | (0,6,33,3) | - | (0,3,17,2) |
Patients on immunomodulatory agent at sampling | 4 | 2 | 2 | 2 |
Mean Pulmonary Arterial Pressure (mm Hg) | 54.9 (15.6) | 49.4 (13.7) | ||
Pulmonary vascular resistance (dynes) | 870 (488) | 753 (448) | ||
6 minute walk distance: Imperial only (m) | 202 (158) | 378 (59) | ||
ISWD: Sheffield only (m) | 214 (169) | 248 (246) | ||
Cardiac Output (L/min) | 4.8 (1.4) | 5.0 (2.0) | ||
Mean pulmonary arterial wedge pressure (mm Hg) | 10.4 (3.8) | 10.8 (3.2) |
Continuous variables described as mean (standard deviation)